Ir(III) Complexes Convert Cold to Hot Tumors via Ferroptosis/Necroptosis‐Driven Immunogenic Cell Death and Photosensitized CD47 Downregulation
Advanced Science · 2026-02 · 13 (8)
DOI: 10.1002/advs.202514256 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 26.11.2025. Verfasst von Long-Bo Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry, Sun Yat-Sen University, Guangzhou, 510275, P. R. China. Hauptthemen laut MEDLINE: CD47 Antigen, Ferroptosis, Photochemotherapy, Photosensitizing Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Photosensitizers engineered for spatiotemporal modulation of cluster of differentiation 47 (CD47) in hypoxic tumor microenvironments (TMEs) disrupt immunosuppressive circuits. Herein, we develop two Ir(III) complexes ( Ir1 and Ir2 ) that function as photodynamic therapy (PDT) agents via Type‐I/II mechanisms, overcoming hypoxic constraints. Under 630 nm irradiation, Ir1 ‐mediated PDT ROS‐dependently downregulates CD47, enabling spatial control that circumvents hematotoxicity. Concurrently, Ir1 ‐mediated PDT triggers immunogenic cell death (ICD) via ferroptosis‐necroptosis synergy and blocks the CD47‐SIRPα immune checkpoint, while promoting M1‐polarization of tumor‐associated macrophages. In 4T1 murine breast cancer models, Ir1 ‐PDT achieves potent tumor suppression and transforms immunologically “cold” tumors into “hot” lesions through the synergistic interplay of ICD and CD47 pathway disruption. Collectively, this work establishes a photodynamic CD47‐signaling platform for precise immune modulation, offering a clinically translatable alternative to conventional CD47‐targeting therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry, Sun Yat-Sen University, Guangzhou, 510275, P. R. China.
- Guangdong Basic Research Center of Excellence for Functional Molecular Engineering, Guangzhou, 510006, P. R. China.
- State Key Laboratory of Anti-Infective Drug Discovery and Development, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, P. R. China.
ORCID-Profile: Cai-Ping Tan
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Yu, L. B., Wang, P., Shen, Q. H., Guan, Q. X., Li, Z. Y., Han, Y. Y., Zhang, X. Y., Hu, Q. Y., & Tan, C. P. (2026). Ir(III) Complexes Convert Cold to Hot Tumors via Ferroptosis/Necroptosis‐Driven Immunogenic Cell Death and Photosensitized CD47 Downregulation. Advanced Science, 13(8). https://doi.org/10.1002/advs.202514256
Vancouver
Yu LB, Wang P, Shen QH, Guan QX, Li ZY, Han YY, et al. Ir(III) Complexes Convert Cold to Hot Tumors via Ferroptosis/Necroptosis‐Driven Immunogenic Cell Death and Photosensitized CD47 Downregulation. Advanced Science. 2026;13(8). doi:10.1002/advs.202514256
BibTeX
@article{Yu2026,
author = {Yu, Long-Bo and Wang, Peng and Shen, Qing-Hua and Guan, Qi-Xin and Li, Zhi-Yuan and Han, Ying-Ying and Zhang, Xin-Yi and Hu, Qing-Yuan and Tan, Cai-Ping},
title = {Ir(III) Complexes Convert Cold to Hot Tumors via Ferroptosis/Necroptosis‐Driven Immunogenic Cell Death and Photosensitized CD47 Downregulation},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {8},
doi = {10.1002/advs.202514256}
}
EUVIMED